Foster City, CA, United States of America

Juan Wang

This inventor holds 1 USPTO granted patent and 12 published patent applications and 1 EPO patent. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan Wang. Retrieved from https://idiyas.com/inventor/juan-wang-7cpcqgbe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Juan Wang in Antidote Formulations

Introduction

Juan Wang is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidote formulations. His innovative work has led to the creation of a patented solution that addresses critical medical needs.

Latest Patents

Juan Wang holds a patent for "Lyophilized formulations for factor Xa antidote." This patent relates to solutions and methods for preparing lyophilized formulations of factor Xa (fXa) antidotes. The formulation includes a fXa antidote, a solubilizing agent, a stabilizer, and a crystalline component, ensuring that the formulation does not collapse during lyophilization. This innovation is crucial for enhancing the stability and efficacy of antidotes used in medical treatments.

Career Highlights

Throughout his career, Juan Wang has worked with notable companies in the pharmaceutical industry. He has been associated with Alexion Pharmaceuticals, Inc. and Portola Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in antidote development.

Collaborations

Juan has collaborated with talented professionals in his field, including Gregory Allan Sacha and Phuong Nguyen. These collaborations have fostered an environment of innovation and have led to advancements in the pharmaceutical sector.

Conclusion

Juan Wang's contributions to the development of lyophilized formulations for factor Xa antidotes highlight his role as a key innovator in the pharmaceutical industry. His work not only showcases his expertise but also emphasizes the importance of innovation in addressing medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…